Gabapentin in the treatment of severe sweating experienced by advanced cancer patients

Giampiero Porzio, Federica Aielli, Lucilla Verna, Claudio Porto, Paolo Aloisi, Katia Cannita, Enrico Ricevuto, Paolo Marchetti, Corrado Ficorella

Research output: Contribution to journalArticle

Abstract

Nine patients with advanced cancer suffering from idiopathic severe sweating were treated with gabapentin (600-1,800 mg/day). All patients responded to the treatment; five patients experienced transient drowsiness. Gabapentin seems to be a safe and effective treatment for idiopathic sweating in advanced cancer patients. Further studies are warranted to confirm or refute these results.

Original languageEnglish
Pages (from-to)389-391
Number of pages3
JournalSupportive Care in Cancer
Volume14
Issue number4
DOIs
Publication statusPublished - Apr 2006

Keywords

  • Gabapentin
  • Sweating

ASJC Scopus subject areas

  • Oncology
  • Nursing(all)

Fingerprint Dive into the research topics of 'Gabapentin in the treatment of severe sweating experienced by advanced cancer patients'. Together they form a unique fingerprint.

  • Cite this

    Porzio, G., Aielli, F., Verna, L., Porto, C., Aloisi, P., Cannita, K., Ricevuto, E., Marchetti, P., & Ficorella, C. (2006). Gabapentin in the treatment of severe sweating experienced by advanced cancer patients. Supportive Care in Cancer, 14(4), 389-391. https://doi.org/10.1007/s00520-005-0014-5